US Stock MarketDetailed Quotes
CLRB Cellectar BioSciences
- 2.9600
- -0.1500-4.82%
Close May 28 16:00 ET
- 2.9499
- -0.0101-0.34%
Post 19:37 ET
106.11MMarket Cap-957P/E (TTM)
3.1500High2.9201Low514.12KVolume3.1000Open3.1100Pre Close1.54MTurnover1.93%Turnover RatioLossP/E (Static)35.85MShares4.450052wk High11.65P/B79.07MFloat Cap1.560252wk Low--Dividend TTM26.71MShs Float13678193.1609Historical High--Div YieldTTM7.39%Amplitude1.2500Historical Low2.9860Avg Price1Lot Size
Cellectar BioSciences Stock Forum
Sign in to post a comment
🎯 Ph 2 readouts in Q2 2024...
$Iovance Biotherapeutics(IOVA.US$ Phase 2
$Supernus Pharmaceuticals(SUPN.US$ Phase 2a
$BRANDES INTERNATIONAL ETF(BINV.US$ Phase 2a
$MorphoSys(MOR.US$ Phase 2
$Nuvation Bio(NUVB.US$ Phase 2
$ALX Oncology(ALXO.US$ Phase 2
$BioXcel Therapeutics(BTAI.US$ Phase 2
$Purple Biotech(PPBT.US$ Phase 2
$Arcus Biosciences(RCUS.US$ Phase 2
$Medicenna Therapeutics(MDNAF.US$ Phase 2b
$Affimed NV(AFMD.US$ Phase 2
$Barinthus Biotherapeutics(BRNS.US$ Phase 2b...
$Iovance Biotherapeutics(IOVA.US$ Phase 2
$Supernus Pharmaceuticals(SUPN.US$ Phase 2a
$BRANDES INTERNATIONAL ETF(BINV.US$ Phase 2a
$MorphoSys(MOR.US$ Phase 2
$Nuvation Bio(NUVB.US$ Phase 2
$ALX Oncology(ALXO.US$ Phase 2
$BioXcel Therapeutics(BTAI.US$ Phase 2
$Purple Biotech(PPBT.US$ Phase 2
$Arcus Biosciences(RCUS.US$ Phase 2
$Medicenna Therapeutics(MDNAF.US$ Phase 2b
$Affimed NV(AFMD.US$ Phase 2
$Barinthus Biotherapeutics(BRNS.US$ Phase 2b...
8
2
$Cellectar BioSciences(CLRB.US$ Cellectar Biosciences Reports High Rate of Complete Remission in Investigator Initiated Phase I Study of Iopofosine in Combination with External Beam Radiotherapy in Recurrent Head and Neck Cancer
4 MINUTES AGO, 6:40 AM EST
VIA GLOBENEWSWIRE
4 MINUTES AGO, 6:40 AM EST
VIA GLOBENEWSWIRE
6
$Cellectar BioSciences(CLRB.US$ Cellectar Biosciences Announces Tranche A Warrants Fully Exercised, Providing Proceeds of $44.1 Million![]()
1
$Cellectar BioSciences(CLRB.US$ Cellectar Biosciences Reports Complete Central Nervous System (CNS) Clearance in Relapsed/Refractory Waldenstrom's Macroglobulinemia Patient
2 MINUTES AGO, 6:40 AM EST
VIA GLOBENEWSWIRE![]()
2 MINUTES AGO, 6:40 AM EST
VIA GLOBENEWSWIRE
2
Biotech Stock News 01/12 @ Open 🛎️📰
$Dyne Therapeutics(DYN.US$ 4% Closing of public offering
$Geron(GERN.US$ 4% Participate @ B. Riley Sec. Conf. '24
$ZEALAND PHARMA AS SPON ADR EACH REP 1 ORD SHS(ZEAL.US$ 2% Capital increase
$XOMA Corp(XOMA.US$ 1% Arimoclomol NDA filing accepted
$Cellectar BioSciences(CLRB.US$ 1% Topline results @ conf. call
$CytomX(CTMX.US$ 0% Present @ B. Riley Sec. Conf. '24
$Dyne Therapeutics(DYN.US$ 4% Closing of public offering
$Geron(GERN.US$ 4% Participate @ B. Riley Sec. Conf. '24
$ZEALAND PHARMA AS SPON ADR EACH REP 1 ORD SHS(ZEAL.US$ 2% Capital increase
$XOMA Corp(XOMA.US$ 1% Arimoclomol NDA filing accepted
$Cellectar BioSciences(CLRB.US$ 1% Topline results @ conf. call
$CytomX(CTMX.US$ 0% Present @ B. Riley Sec. Conf. '24
2
$Cellectar BioSciences(CLRB.US$ Cellectar Biosciences Partners with MiBA, a Data Subsidiary of American Oncology Network, to Advance the Treatment of Waldenstrom's Macroglobulinemia in the Community Setting![]()
4
$Cellectar BioSciences (CLRB.US)$ man am I good.... I bought right at the top of the mountain ![]()
![]()
![]()
![]()
![]()
1
$Cellectar BioSciences(CLRB.US$ Oppenheimer Boosts Price Target on Cellectar Biosciences to $11 From $8, Maintains Outperform Rating![]()
$Cellectar BioSciences(CLRB.US$ this will continue til tomorrow
2
No comment yet
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
The Real Wojak : Do you have like a top 3-5 that you like more than all the other ones? This list is way too long
72991267 : Glad I have some $Candel Therapeutics (CADL.US)$ after my disastrous SBFM.